Sign in

CIK 0001061983 · Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
943291317
Phone
(650) 624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,208,275
in 16 filings, $12.2M under 10b5-1 plans

Net −$12,208,275. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Blum Robert I −$9.3M President & CEO sold 33% of stake
  2. Malik Fady Ibraham −$1.4M EVP Research & Development sold 12% of stake
  3. Callos Andrew −$702K EVP, Chief Commercial Officer sold 15% of stake
  4. PARSHALL B LYNNE −$631K Director sold 63% of stake
  5. Landry Robert E −$147K Director sold 20% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-01 PARSHALL B LYNNE Director Sale 10b5-1 −5,000 $74.08 $370K 15,784
2026-05-27 Blum Robert I President & CEO Sale 10b5-1 −7,500 $77.21 $579K 392,830
2026-05-27 Bhanji Muna Director Grant or award +2,851 26,361
2026-05-27 Bhanji Muna Director Grant or award · Non-Qualified Stock Option (Right to Buy) +4,301 4,301
2026-05-27 Daly James M Director Grant or award +2,851 3,239
2026-05-27 Daly James M Director Grant or award · Non-Qualified Stock Option (Right to Buy) +4,301 4,301
2026-05-27 Harrington Robert Arthur Director Grant or award +2,851 21,781
2026-05-27 Harrington Robert Arthur Director Grant or award · Non-Qualified Stock Option (Right to Buy) +4,301 4,301
2026-05-27 HENDERSON JOHN T Director Grant or award +2,851 78,088
2026-05-27 HENDERSON JOHN T Director Grant or award · Non-Qualified Stock Option (Right to Buy) +4,301 4,301
2026-05-27 Kaye Edward M. MD Director Grant or award +2,851 13,216
2026-05-27 Kaye Edward M. MD Director Grant or award · Non-Qualified Stock Option (Right to Buy) +4,301 4,301
2026-05-27 PARSHALL B LYNNE Director Grant or award +2,851 20,784
2026-05-27 PARSHALL B LYNNE Director Grant or award · Non-Qualified Stock Option (Right to Buy) +4,301 4,301
2026-05-27 Landry Robert E Director Grant or award +2,851 10,184
2026-05-27 Landry Robert E Director Grant or award · Non-Qualified Stock Option (Right to Buy) +4,301 4,301
2026-05-27 WIERENGA WENDELL Director Grant or award +2,851 35,488
2026-05-27 WIERENGA WENDELL Director Grant or award · Non-Qualified Stock Option (Right to Buy) +4,301 4,301
2026-05-27 Wysenski Nancy Director Grant or award +2,851 33,917
2026-05-27 Wysenski Nancy Director Grant or award · Non-Qualified Stock Option (Right to Buy) +4,301 4,301

Page 7 of 22 · 429 trades